Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

OPKO Health, Inc. secures $125 million in additional notes issuance from HealthCare Royalty, expanding its financing relationship. This capital is aimed at strengthening its balance sheet and retaining value from its mazdutide royalties.

PUBLIC · OPKAug 13, 2026•about 3 hours ago

Amount Raised

$125 Million

Round Type

Debt Financing

MiamiBiotechnologyHealth CareBiopharma

Investors

Health Care Royalty

Description

OPKO Health, Inc. announced an expansion of its financing relationship with HealthCare Royalty through an additional $125 million notes issuance. These notes are secured by OPKO's royalty interests under its mazdutide license with Eli Lilly. This transaction is intended to provide non-dilutive capital while preserving long-term royalty participation

Company Information

Company

OPKO Health

Location

Miami, Florida, United States

About

OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise, and its novel and proprietary technologies. For more information, visit www.opko.com.

Don't miss OPKO Health's next move

Get an email the moment OPKO Health raises, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you

2 contacts

Verified contactsLuis P., Director, Project Management (PMO), Inc… hidden

Predictive Intelligence

Strategic

ML-powered predictions for OPKO Health's next move

Learn about Strategic plan

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech